ACT-AEC First Annual Meeting

At the ACT-AEC First Annual Meeting, ACT-AEC invited 48 Canadian biotechnology companies to present their work to members of the consortium. ACT-AEC is proud to share the experiences of these companies in connecting with ACT-AEC’s consortium partners. To connect with ACT-AEC, contact us.

Twitter Youtube Linkedin

KM RFA Announcement

June 6, 2025 No Comments

The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices. Knowledge mobilization is a key

Read More »

RFA 5 Announcement

November 22, 2024 No Comments

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were initiated and are led by

Read More »

Canadian Biotech Opportunity

July 16, 2024 No Comments

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies

Read More »

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.